A Kinetic Scout Approach Accelerates Targeted Protein Degrader Development

Angela T Fan,Gillian E Gadbois,Hai-Tsang Huang,Jiewei Jiang,Logan H Sigua,Emily R Smith,Sitong Wu,Kara Dunne-Dombrink,Pavitra Goyal,Andrew J Tao,William Broad Sellers,Eric S Fischer,Katherine A Donovan,Fleur Ferguson

DOI: https://doi.org/10.1101/2024.09.17.612508

2024-09-21

Abstract:Bifunctional molecules such as targeted protein degraders induce proximity to promote gain-of-function pharmacology. These powerful approaches have gained broad traction across academia and the pharmaceutical industry, leading to an intensive focus on strategies that can accelerate their identification and optimization. We and others have previously used chemical proteomics to map degradable target space, and these datasets have been used to develop and train multiparameter models to extend degradability predictions across the proteome. In this study, we now turn our attention to develop generalizable chemistry strategies to accelerate the development of new bifunctional degraders. We implement lysine-targeted reversible-covalent chemistry to rationally tune the binding kinetics at the protein-of-interest across a set of 25 targets. We define an unbiased workflow consisting of global proteomics analysis, IP/MS of ternary complexes and the E-STUB assay, to mechanistically characterize the effects of ligand residence time on targeted protein degradation and formulate hypotheses about the rate-limiting step of degradation for each target. Our key finding is that target residence time is a major determinant of degrader activity, and this can be rapidly and rationally tuned through the synthesis of a minimal number of analogues to accelerate early degrader discovery and optimization efforts.

Pharmacology and Toxicology

What problem does this paper attempt to address?

The paper attempts to address the issue of how to systematically adjust the dissociation rate (residence time) of target proteins and ligands during the development of protein degradation drugs, in order to accelerate the discovery and optimization of novel bifunctional degraders. Specifically, the researchers used reversible covalent chemistry to design different chemical modifications targeting lysine sites in a series of target proteins, thereby achieving rational control of binding kinetics. Through global proteomics analysis, immunoprecipitation mass spectrometry (IP/MS), and E-STUB experiments, the researchers systematically evaluated the impact of different dissociation times on the degradation effect of target proteins and proposed methods for formulating rational drug optimization strategies based on these data. This work emphasizes the important role of dissociation time in improving degradation efficiency and selectivity, similar to the impact of changing linker length, indicating that incorporating systematic adjustments of dissociation time in the early stages of drug design can significantly accelerate the development process of degraders.